Visual analogue scale (VAS) as a monitoring tool for daily changes in asthma symptoms in adolescents: a prospective study.
Hyekyun RheeMichael BelyeaJennifer MammenPublished in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2017)
VAS is a valid tool capturing diurnal changes in symptoms reflected in a multi-item symptom diary. Moreover, VAS is a valid measure predicting concurrent and future asthma control. The findings suggest VAS can be a simple alternative to daily dairies for daily symptom monitoring, which can provide invaluable information about current and future asthma control without substantially increasing self-monitoring burdens for adolescent patients. Clinical Trial Registration NCT01696357. Registered 18 September 2012.
Keyphrases
- chronic obstructive pulmonary disease
- physical activity
- lung function
- clinical trial
- young adults
- end stage renal disease
- allergic rhinitis
- ejection fraction
- current status
- patient reported
- chronic kidney disease
- mental health
- peritoneal dialysis
- sleep quality
- randomized controlled trial
- cystic fibrosis
- study protocol
- depressive symptoms
- phase ii
- patient reported outcomes
- childhood cancer
- psychometric properties